Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Inflammatory Breast Neoplasms
×
Albumin-Bound Paclitaxel
×
Clear all
Filters
3
NCT01583426
2020-08-06
GeparSepto
GBG Forschungs GmbH
Phase 3
Completed
1,229 enrolled